No published trial results for this day.
Updated from the previous day
| Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|
| ARIKAYCE Mycobacterium Infections, Nontuberculous | Insmed (INSM) | Met | $136.00 | $147.22 | +8.25% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.